Search results
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 3 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
Novavax, With A 369% Gain, Tears Ahead Again On A Key FDA Move
Investor's Business Daily· 19 minutes agoPfizer and Moderna are also planning to prepare JN.1-focused boosters. Novavax stock has been on a...
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Is Moderna Stock a Buy Now That It's a 2-Product Company? | The Motley Fool
The Motley Fool· 3 days agoThe shortened trading week that ended on May 31 was a strange one for the vaccine developer Moderna...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 3 days agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 19 hours agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 3 days agoModerna (NASDAQ: MRNA) jumped into the limelight when it started developing a coronavirus vaccine candidate. And the stock soared as the vaccine raced...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 6 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 6 days agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year — ...
Why Moderna Stock Is Sinking This Week | The Motley Fool
The Motley Fool· 7 days agoShares of Moderna (MRNA 2.41%) were sinking 9% lower this week as of Thursday's market close,...
